| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |